Cellular and molecular parameters of mesothelioma

Malignant mesotheliomas (MM) are neoplasms arising from mesothelial cells that line the body cavities, most commonly the pleural and peritoneal cavities. Although traditionally recognized as associated with occupational asbestos exposures, MMs can appear in individuals with no documented exposures t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cellular biochemistry 2006-07, Vol.98 (4), p.723-734
Hauptverfasser: Ramos-Nino, Maria E., Testa, Joseph R., Altomare, Deborah A., Pass, Harvey I., Carbone, Michele, Bocchetta, Maurizio, Mossman, Brooke T.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 734
container_issue 4
container_start_page 723
container_title Journal of cellular biochemistry
container_volume 98
creator Ramos-Nino, Maria E.
Testa, Joseph R.
Altomare, Deborah A.
Pass, Harvey I.
Carbone, Michele
Bocchetta, Maurizio
Mossman, Brooke T.
description Malignant mesotheliomas (MM) are neoplasms arising from mesothelial cells that line the body cavities, most commonly the pleural and peritoneal cavities. Although traditionally recognized as associated with occupational asbestos exposures, MMs can appear in individuals with no documented exposures to asbestos fibers, and emerging data suggest that genetic susceptibility and simian virus 40 (SV40) infections also facilitate the development of MMs. Both asbestos exposure and transfection of human mesothelial cells with SV40 large and small antigens (Tag, tag) cause genetic modifications and cell signaling events, most notably the induction of cell survival pathways and activation of receptors, and other proteins that favor the growth and establishment of MMs as well as their resistance to chemotherapy. Recent advances in high‐throughput technologies documenting gene and protein expression in patients and animal models of MMs can now be validated in human MM tissue arrays. These have revealed expression profiles that allow more accurate diagnosis and prognosis of MMs. More importantly, serum proteomics has revealed two new candidates (osteopontin and serum mesothelin‐related protein or SMRP) potentially useful in screening individuals for MMs. These mechanistic approaches offer new hope for early detection and treatment of these devastating tumors. J. Cell. Biochem. 98: 723–734, 2006. © 2006 Wiley‐Liss, Inc.
doi_str_mv 10.1002/jcb.20828
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2766267</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20866398</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5488-dc3e59f678b198c2cc05a3f7b23cf63e161acc805d9d62600f3f38e6a59f474e3</originalsourceid><addsrcrecordid>eNp1kMlOwzAURS0EgjIs-AHUFRKLtB4S29kgQUQLFQLEINhZrvMCgaQudsLw95i2TAtWluVzj9-7CG0T3CMY0_6jGfcollQuoQ7BqYhiHsfLqIMFwxFlhK6hde8fMcZpyugqWiNcpAkWsoNIBlXVVtp19STv1rYCM7tNtdM1NOB81xbdGrxtHqAqba030UqhKw9bi3MD3QyOrrPj6PR8eJIdnEYmiaWMcsMgSQsu5Jik0lBjcKJZIcaUmYIzIJxoYyRO8jTnlGNcsIJJ4DqEYhED20D7c--0HdeQG5g0Tldq6spau3dldan-vkzKB3VvXxQVPAhFEOwuBM4-t-AbVZfehHX1BGzrVWiMc5bKAO7NQeOs9w6K708IVp8Fq1CwmhUc2J3fU_2Qi0YD0J8Dr2UF7_-b1Cg7_FJG80TpG3j7Tmj3pMIWIlG3Z0M1uri7us7iSzVgHw4DlPM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20866398</pqid></control><display><type>article</type><title>Cellular and molecular parameters of mesothelioma</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Ramos-Nino, Maria E. ; Testa, Joseph R. ; Altomare, Deborah A. ; Pass, Harvey I. ; Carbone, Michele ; Bocchetta, Maurizio ; Mossman, Brooke T.</creator><creatorcontrib>Ramos-Nino, Maria E. ; Testa, Joseph R. ; Altomare, Deborah A. ; Pass, Harvey I. ; Carbone, Michele ; Bocchetta, Maurizio ; Mossman, Brooke T.</creatorcontrib><description>Malignant mesotheliomas (MM) are neoplasms arising from mesothelial cells that line the body cavities, most commonly the pleural and peritoneal cavities. Although traditionally recognized as associated with occupational asbestos exposures, MMs can appear in individuals with no documented exposures to asbestos fibers, and emerging data suggest that genetic susceptibility and simian virus 40 (SV40) infections also facilitate the development of MMs. Both asbestos exposure and transfection of human mesothelial cells with SV40 large and small antigens (Tag, tag) cause genetic modifications and cell signaling events, most notably the induction of cell survival pathways and activation of receptors, and other proteins that favor the growth and establishment of MMs as well as their resistance to chemotherapy. Recent advances in high‐throughput technologies documenting gene and protein expression in patients and animal models of MMs can now be validated in human MM tissue arrays. These have revealed expression profiles that allow more accurate diagnosis and prognosis of MMs. More importantly, serum proteomics has revealed two new candidates (osteopontin and serum mesothelin‐related protein or SMRP) potentially useful in screening individuals for MMs. These mechanistic approaches offer new hope for early detection and treatment of these devastating tumors. J. Cell. Biochem. 98: 723–734, 2006. © 2006 Wiley‐Liss, Inc.</description><identifier>ISSN: 0730-2312</identifier><identifier>EISSN: 1097-4644</identifier><identifier>DOI: 10.1002/jcb.20828</identifier><identifier>PMID: 16795078</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Animals ; asbestos ; Asbestos - adverse effects ; cancer ; Cell Transformation, Neoplastic ; Cell Transformation, Viral ; Humans ; mesothelioma ; Mesothelioma - diagnosis ; Mesothelioma - etiology ; Mesothelioma - metabolism ; Mesothelioma - therapy ; Mesothelioma - virology ; Peritoneal Neoplasms - diagnosis ; Peritoneal Neoplasms - etiology ; Peritoneal Neoplasms - metabolism ; Peritoneal Neoplasms - therapy ; Peritoneal Neoplasms - virology ; Pleural Neoplasms - diagnosis ; Pleural Neoplasms - etiology ; Pleural Neoplasms - metabolism ; Pleural Neoplasms - therapy ; Pleural Neoplasms - virology ; Polyomavirus Infections - diagnosis ; Polyomavirus Infections - metabolism ; Polyomavirus Infections - therapy ; Simian virus 40 ; SV40 ; Tumor Virus Infections - diagnosis ; Tumor Virus Infections - metabolism ; Tumor Virus Infections - therapy</subject><ispartof>Journal of cellular biochemistry, 2006-07, Vol.98 (4), p.723-734</ispartof><rights>Copyright © 2006 Wiley‐Liss, Inc.</rights><rights>2006 Wiley-Liss, Inc.</rights><rights>2006 Wiley-Liss, Inc. 2006</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5488-dc3e59f678b198c2cc05a3f7b23cf63e161acc805d9d62600f3f38e6a59f474e3</citedby><cites>FETCH-LOGICAL-c5488-dc3e59f678b198c2cc05a3f7b23cf63e161acc805d9d62600f3f38e6a59f474e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjcb.20828$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjcb.20828$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16795078$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ramos-Nino, Maria E.</creatorcontrib><creatorcontrib>Testa, Joseph R.</creatorcontrib><creatorcontrib>Altomare, Deborah A.</creatorcontrib><creatorcontrib>Pass, Harvey I.</creatorcontrib><creatorcontrib>Carbone, Michele</creatorcontrib><creatorcontrib>Bocchetta, Maurizio</creatorcontrib><creatorcontrib>Mossman, Brooke T.</creatorcontrib><title>Cellular and molecular parameters of mesothelioma</title><title>Journal of cellular biochemistry</title><addtitle>J. Cell. Biochem</addtitle><description>Malignant mesotheliomas (MM) are neoplasms arising from mesothelial cells that line the body cavities, most commonly the pleural and peritoneal cavities. Although traditionally recognized as associated with occupational asbestos exposures, MMs can appear in individuals with no documented exposures to asbestos fibers, and emerging data suggest that genetic susceptibility and simian virus 40 (SV40) infections also facilitate the development of MMs. Both asbestos exposure and transfection of human mesothelial cells with SV40 large and small antigens (Tag, tag) cause genetic modifications and cell signaling events, most notably the induction of cell survival pathways and activation of receptors, and other proteins that favor the growth and establishment of MMs as well as their resistance to chemotherapy. Recent advances in high‐throughput technologies documenting gene and protein expression in patients and animal models of MMs can now be validated in human MM tissue arrays. These have revealed expression profiles that allow more accurate diagnosis and prognosis of MMs. More importantly, serum proteomics has revealed two new candidates (osteopontin and serum mesothelin‐related protein or SMRP) potentially useful in screening individuals for MMs. These mechanistic approaches offer new hope for early detection and treatment of these devastating tumors. J. Cell. Biochem. 98: 723–734, 2006. © 2006 Wiley‐Liss, Inc.</description><subject>Animals</subject><subject>asbestos</subject><subject>Asbestos - adverse effects</subject><subject>cancer</subject><subject>Cell Transformation, Neoplastic</subject><subject>Cell Transformation, Viral</subject><subject>Humans</subject><subject>mesothelioma</subject><subject>Mesothelioma - diagnosis</subject><subject>Mesothelioma - etiology</subject><subject>Mesothelioma - metabolism</subject><subject>Mesothelioma - therapy</subject><subject>Mesothelioma - virology</subject><subject>Peritoneal Neoplasms - diagnosis</subject><subject>Peritoneal Neoplasms - etiology</subject><subject>Peritoneal Neoplasms - metabolism</subject><subject>Peritoneal Neoplasms - therapy</subject><subject>Peritoneal Neoplasms - virology</subject><subject>Pleural Neoplasms - diagnosis</subject><subject>Pleural Neoplasms - etiology</subject><subject>Pleural Neoplasms - metabolism</subject><subject>Pleural Neoplasms - therapy</subject><subject>Pleural Neoplasms - virology</subject><subject>Polyomavirus Infections - diagnosis</subject><subject>Polyomavirus Infections - metabolism</subject><subject>Polyomavirus Infections - therapy</subject><subject>Simian virus 40</subject><subject>SV40</subject><subject>Tumor Virus Infections - diagnosis</subject><subject>Tumor Virus Infections - metabolism</subject><subject>Tumor Virus Infections - therapy</subject><issn>0730-2312</issn><issn>1097-4644</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kMlOwzAURS0EgjIs-AHUFRKLtB4S29kgQUQLFQLEINhZrvMCgaQudsLw95i2TAtWluVzj9-7CG0T3CMY0_6jGfcollQuoQ7BqYhiHsfLqIMFwxFlhK6hde8fMcZpyugqWiNcpAkWsoNIBlXVVtp19STv1rYCM7tNtdM1NOB81xbdGrxtHqAqba030UqhKw9bi3MD3QyOrrPj6PR8eJIdnEYmiaWMcsMgSQsu5Jik0lBjcKJZIcaUmYIzIJxoYyRO8jTnlGNcsIJJ4DqEYhED20D7c--0HdeQG5g0Tldq6spau3dldan-vkzKB3VvXxQVPAhFEOwuBM4-t-AbVZfehHX1BGzrVWiMc5bKAO7NQeOs9w6K708IVp8Fq1CwmhUc2J3fU_2Qi0YD0J8Dr2UF7_-b1Cg7_FJG80TpG3j7Tmj3pMIWIlG3Z0M1uri7us7iSzVgHw4DlPM</recordid><startdate>20060701</startdate><enddate>20060701</enddate><creator>Ramos-Nino, Maria E.</creator><creator>Testa, Joseph R.</creator><creator>Altomare, Deborah A.</creator><creator>Pass, Harvey I.</creator><creator>Carbone, Michele</creator><creator>Bocchetta, Maurizio</creator><creator>Mossman, Brooke T.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope><scope>5PM</scope></search><sort><creationdate>20060701</creationdate><title>Cellular and molecular parameters of mesothelioma</title><author>Ramos-Nino, Maria E. ; Testa, Joseph R. ; Altomare, Deborah A. ; Pass, Harvey I. ; Carbone, Michele ; Bocchetta, Maurizio ; Mossman, Brooke T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5488-dc3e59f678b198c2cc05a3f7b23cf63e161acc805d9d62600f3f38e6a59f474e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Animals</topic><topic>asbestos</topic><topic>Asbestos - adverse effects</topic><topic>cancer</topic><topic>Cell Transformation, Neoplastic</topic><topic>Cell Transformation, Viral</topic><topic>Humans</topic><topic>mesothelioma</topic><topic>Mesothelioma - diagnosis</topic><topic>Mesothelioma - etiology</topic><topic>Mesothelioma - metabolism</topic><topic>Mesothelioma - therapy</topic><topic>Mesothelioma - virology</topic><topic>Peritoneal Neoplasms - diagnosis</topic><topic>Peritoneal Neoplasms - etiology</topic><topic>Peritoneal Neoplasms - metabolism</topic><topic>Peritoneal Neoplasms - therapy</topic><topic>Peritoneal Neoplasms - virology</topic><topic>Pleural Neoplasms - diagnosis</topic><topic>Pleural Neoplasms - etiology</topic><topic>Pleural Neoplasms - metabolism</topic><topic>Pleural Neoplasms - therapy</topic><topic>Pleural Neoplasms - virology</topic><topic>Polyomavirus Infections - diagnosis</topic><topic>Polyomavirus Infections - metabolism</topic><topic>Polyomavirus Infections - therapy</topic><topic>Simian virus 40</topic><topic>SV40</topic><topic>Tumor Virus Infections - diagnosis</topic><topic>Tumor Virus Infections - metabolism</topic><topic>Tumor Virus Infections - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ramos-Nino, Maria E.</creatorcontrib><creatorcontrib>Testa, Joseph R.</creatorcontrib><creatorcontrib>Altomare, Deborah A.</creatorcontrib><creatorcontrib>Pass, Harvey I.</creatorcontrib><creatorcontrib>Carbone, Michele</creatorcontrib><creatorcontrib>Bocchetta, Maurizio</creatorcontrib><creatorcontrib>Mossman, Brooke T.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of cellular biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ramos-Nino, Maria E.</au><au>Testa, Joseph R.</au><au>Altomare, Deborah A.</au><au>Pass, Harvey I.</au><au>Carbone, Michele</au><au>Bocchetta, Maurizio</au><au>Mossman, Brooke T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cellular and molecular parameters of mesothelioma</atitle><jtitle>Journal of cellular biochemistry</jtitle><addtitle>J. Cell. Biochem</addtitle><date>2006-07-01</date><risdate>2006</risdate><volume>98</volume><issue>4</issue><spage>723</spage><epage>734</epage><pages>723-734</pages><issn>0730-2312</issn><eissn>1097-4644</eissn><abstract>Malignant mesotheliomas (MM) are neoplasms arising from mesothelial cells that line the body cavities, most commonly the pleural and peritoneal cavities. Although traditionally recognized as associated with occupational asbestos exposures, MMs can appear in individuals with no documented exposures to asbestos fibers, and emerging data suggest that genetic susceptibility and simian virus 40 (SV40) infections also facilitate the development of MMs. Both asbestos exposure and transfection of human mesothelial cells with SV40 large and small antigens (Tag, tag) cause genetic modifications and cell signaling events, most notably the induction of cell survival pathways and activation of receptors, and other proteins that favor the growth and establishment of MMs as well as their resistance to chemotherapy. Recent advances in high‐throughput technologies documenting gene and protein expression in patients and animal models of MMs can now be validated in human MM tissue arrays. These have revealed expression profiles that allow more accurate diagnosis and prognosis of MMs. More importantly, serum proteomics has revealed two new candidates (osteopontin and serum mesothelin‐related protein or SMRP) potentially useful in screening individuals for MMs. These mechanistic approaches offer new hope for early detection and treatment of these devastating tumors. J. Cell. Biochem. 98: 723–734, 2006. © 2006 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>16795078</pmid><doi>10.1002/jcb.20828</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0730-2312
ispartof Journal of cellular biochemistry, 2006-07, Vol.98 (4), p.723-734
issn 0730-2312
1097-4644
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2766267
source MEDLINE; Access via Wiley Online Library
subjects Animals
asbestos
Asbestos - adverse effects
cancer
Cell Transformation, Neoplastic
Cell Transformation, Viral
Humans
mesothelioma
Mesothelioma - diagnosis
Mesothelioma - etiology
Mesothelioma - metabolism
Mesothelioma - therapy
Mesothelioma - virology
Peritoneal Neoplasms - diagnosis
Peritoneal Neoplasms - etiology
Peritoneal Neoplasms - metabolism
Peritoneal Neoplasms - therapy
Peritoneal Neoplasms - virology
Pleural Neoplasms - diagnosis
Pleural Neoplasms - etiology
Pleural Neoplasms - metabolism
Pleural Neoplasms - therapy
Pleural Neoplasms - virology
Polyomavirus Infections - diagnosis
Polyomavirus Infections - metabolism
Polyomavirus Infections - therapy
Simian virus 40
SV40
Tumor Virus Infections - diagnosis
Tumor Virus Infections - metabolism
Tumor Virus Infections - therapy
title Cellular and molecular parameters of mesothelioma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T13%3A04%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cellular%20and%20molecular%20parameters%20of%20mesothelioma&rft.jtitle=Journal%20of%20cellular%20biochemistry&rft.au=Ramos-Nino,%20Maria%20E.&rft.date=2006-07-01&rft.volume=98&rft.issue=4&rft.spage=723&rft.epage=734&rft.pages=723-734&rft.issn=0730-2312&rft.eissn=1097-4644&rft_id=info:doi/10.1002/jcb.20828&rft_dat=%3Cproquest_pubme%3E20866398%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20866398&rft_id=info:pmid/16795078&rfr_iscdi=true